Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc.
WKN: A0DN17 / Symbol: PBH / Name: Prestige Consumer Healthcare / Aktie / Lebensmittel- & Medikamentenhandel / Small Cap /
65,00 €
1,56 %
Prestige Consumer Healthcare Inc. (NYSE: PBH) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target raised by analysts at DA Davidson from $93.00 to $95.00. They now have a "buy" rating on the stock.
Ratings data for PBH provided by MarketBeat
Neueste Beiträge
BTIG_Research in Galmed Pharmaceuticals Ltd. diskutieren